Transient Mitomycin C-treatment of human corneal epithelial cells and fibroblasts alters cell migration, cytokine secretion, and matrix accumulation
A single application of Mitomycin C (MMC) is used clinically in ophthalmology to reduce scarring and enhance wound resolution after surgery. Here we show in vitro that a 3-hour MMC treatment of primary and telomerase immortalized human corneal limbal epithelial (HCLE) cells impacts their migration and adhesion. Transient MMC treatment induces HCLE expression of senescence associated secretory factors, cytokine secretion, and deposition of laminin 332 for several days. Transient MMC treatment also reduces migration and deposition of transforming growth factor-β1 (TGFβ1)-stimulated collagen by corneal fibroblasts. Using conditioned media from control and MMC treated cells, we demonstrate that factors secreted by MMC-treated corneal epithelial cells attenuate collagen deposition by HCFs whereas those secreted by MMC-treated HCFs do not. These studies are the first to probe the roles played by corneal epithelial cells in reducing collagen deposition by corneal fibroblasts in response to MMC.- Sci Rep
- 4.6
- 2019 Sep 25;9(1):13905.
- Human
- 抗体芯片
- 生物标志物
- 生物标志物
- 上皮细胞
- C5a,IL-4,IL-27,CD40 Ligand,IL-5,IL-32 alpha,G-CSF,IL-6,CXCL10/IP-10,GM-CSF,IL-8,CXCL11/I-TAC,CXCL1/GRO alpha,IL-10,CCL2/MCP-1,CCL1/I-309,IL-12 p70,MIF,ICAM-1,IL-13,MIP-1 alpha/MIP-1 beta,IFN-gamma,IL-16,CCL5/RANTES,IL-1 alpha,IL-17,CXCL12/SDF-1,IL-1 beta,IL-17E,Serpin E1/PAI-1,IL-1ra,IL-18,TNF-alpha,IL-2,IL-21,TREM-1
相关货号
LXAH036-2
Abstract
A single application of Mitomycin C (MMC) is used clinically in ophthalmology to reduce scarring and enhance wound resolution after surgery. Here we show in vitro that a 3-hour MMC treatment of primary and telomerase immortalized human corneal limbal epithelial (HCLE) cells impacts their migration and adhesion. Transient MMC treatment induces HCLE expression of senescence associated secretory factors, cytokine secretion, and deposition of laminin 332 for several days. Transient MMC treatment also reduces migration and deposition of transforming growth factor-β1 (TGFβ1)-stimulated collagen by corneal fibroblasts. Using conditioned media from control and MMC treated cells, we demonstrate that factors secreted by MMC-treated corneal epithelial cells attenuate collagen deposition by HCFs whereas those secreted by MMC-treated HCFs do not. These studies are the first to probe the roles played by corneal epithelial cells in reducing collagen deposition by corneal fibroblasts in response to MMC.
金课堂之文献解析 文献原文请点击
本网站销售的所有产品及服务均不得用于人类或动物之临床诊断或治疗,仅可用于工业或者科研等非医疗目的。